{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:14:21Z","timestamp":1784549661298,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00595-025-03058-2","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T02:23:25Z","timestamp":1751077405000},"page":"1710-1722","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The albumin-myosteatosis gauge predicts the response to neoadjuvant chemotherapy for locally advanced gastric cancer"],"prefix":"10.1007","volume":"55","author":[{"given":"Jing-Min","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"issue":"3","key":"3058_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3058_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-007-0448-1","volume":"11","author":"K Ott","year":"2008","unstructured":"Ott K, Lordick F, Herrmann K, Krause BJ, Schuhmacher C, Siewert JR. The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies. Gastric Cancer. 2008;11(1):1\u20139.","journal-title":"Gastric Cancer"},{"issue":"26","key":"3058_CR3","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1200\/JCO.20.02914","volume":"39","author":"YK Kang","year":"2021","unstructured":"Kang YK, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, et al. PRODIGY: a phase III study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced gastric cancer. J Clin Oncol. 2021;39(26):2903\u201313.","journal-title":"J Clin Oncol"},{"issue":"8","key":"3058_CR4","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S1470-2045(21)00297-7","volume":"22","author":"X Zhang","year":"2021","unstructured":"Zhang X, Liang H, Li Z, Xue Y, Wang Y, Zhou Z, et al. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial. Lancet Oncol. 2021;22(8):1081\u201392.","journal-title":"Lancet Oncol"},{"issue":"1","key":"3058_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10120-018-0882-2","volume":"22","author":"SK Kamarajah","year":"2019","unstructured":"Kamarajah SK, Bundred J, Tan BHL. Body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis. Gastric Cancer. 2019;22(1):10\u201322.","journal-title":"Gastric Cancer"},{"issue":"1","key":"3058_CR6","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41598-022-27238-z","volume":"13","author":"Y Guo","year":"2023","unstructured":"Guo Y, Ren Y, Zhu L, Yang L, Zheng C. Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis. Sci Rep. 2023;13(1):934.","journal-title":"Sci Rep"},{"issue":"1","key":"3058_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcsm.13126","volume":"14","author":"P Fang","year":"2023","unstructured":"Fang P, Zhou J, Xiao X, Yang Y, Luan S, Liang Z, et al. The prognostic value of sarcopenia in oesophageal cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14(1):3\u201316.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"3058_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jcsm.12484","volume":"11","author":"UT Hacker","year":"2020","unstructured":"Hacker UT, Hasenclever D, Linder N, Stocker G, Chung HC, Kang YK, et al. Prognostic role of body composition parameters in gastric\/gastroesophageal junction cancer patients from the EXPAND trial. J Cachexia Sarcopenia Muscle. 2020;11(1):135\u201344.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"5","key":"3058_CR9","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1016\/j.clnu.2020.11.007","volume":"40","author":"QT Dong","year":"2021","unstructured":"Dong QT, Cai HY, Zhang Z, Zou HB, Dong WX, Wang WB, et al. Influence of body composition, muscle strength, and physical performance on the postoperative complications and survival after radical gastrectomy for gastric cancer: a comprehensive analysis from a large-scale prospective study. Clin Nutr. 2021;40(5):3360\u20139.","journal-title":"Clin Nutr"},{"issue":"8","key":"3058_CR10","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1016\/j.clnu.2021.06.021","volume":"40","author":"JX Lin","year":"2021","unstructured":"Lin JX, Tang YH, Zhou WX, Desiderio J, Parisi A, Xie JW, et al. Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: a multicenter, international study. Clin Nutr. 2021;40(8):4980\u20137.","journal-title":"Clin Nutr"},{"issue":"2","key":"3058_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/jcsm.13183","volume":"14","author":"Y Kim","year":"2023","unstructured":"Kim Y, Lee JH, Cho ES, Lee HS, Shin SJ, Park EJ, et al. Albumin-myosteatosis gauge as a novel prognostic risk factor in patients with non-metastatic colorectal cancer. J Cachexia Sarcopenia Muscle. 2023;14(2):860\u20138.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"41","key":"3058_CR12","doi-asserted-by":"publisher","first-page":"6258","DOI":"10.3748\/wjg.v25.i41.6258","volume":"25","author":"JX Lin","year":"2019","unstructured":"Lin JX, Tang YH, Wang JB, Lu J, Chen QY, Cao LL, et al. Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients. World J Gastroenterol. 2019;25(41):6258\u201372.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"3058_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","volume":"14","author":"JGC Association","year":"2011","unstructured":"Association JGC. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101\u201312.","journal-title":"Gastric Cancer"},{"issue":"2","key":"3058_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer."},{"issue":"4","key":"3058_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjon.2024.100436","volume":"11","author":"L Luo","year":"2024","unstructured":"Luo L, Fan Y, Wang Y, Wang Z, Zhou J. Prevalence and clinical outcomes of sarcopenia in patients with esophageal, gastric or colorectal cancers receiving preoperative neoadjuvant therapy: a meta-analysis. Asia Pac J Oncol Nurs. 2024;11(4): 100436.","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"4","key":"3058_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412\u201323.","journal-title":"Age Ageing"},{"issue":"1","key":"3058_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruy\u00e8re O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16\u201331.","journal-title":"Age Ageing"},{"issue":"3","key":"3058_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108004","volume":"50","author":"HL Zheng","year":"2024","unstructured":"Zheng HL, Wei LH, Xu BB, Zheng HH, Xue Z, Chen QY, et al. Prognostic value of preoperative sarcopenia in gastric cancer: a 10-year follow-up study. Eur J Surg Oncol. 2024;50(3): 108004.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"3058_CR19","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s10120-015-0546-4","volume":"19","author":"Y Fukuda","year":"2016","unstructured":"Fukuda Y, Yamamoto K, Hirao M, Nishikawa K, Nagatsuma Y, Nakayama T, et al. Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy. Gastric Cancer. 2016;19(3):986\u201393.","journal-title":"Gastric Cancer"},{"issue":"9","key":"3058_CR20","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1016\/j.ejso.2021.02.008","volume":"47","author":"LC Murnane","year":"2021","unstructured":"Murnane LC, Forsyth AK, Koukounaras J, Pilgrim CH, Shaw K, Brown WA, et al. Myosteatosis predicts higher complications and reduced overall survival following radical oesophageal and gastric cancer surgery. Eur J Surg Oncol. 2021;47(9):2295\u2013303.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"3058_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/ags3.12452","volume":"5","author":"R Matsui","year":"2021","unstructured":"Matsui R, Inaki N, Tsuji T. Impact of preoperative muscle quality on postoperative severe complications after radical gastrectomy for gastric cancer patients. Ann Gastroenterol Surg. 2021;5(4):510\u20138.","journal-title":"Ann Gastroenterol Surg"},{"issue":"6","key":"3058_CR22","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00384-016-2538-1","volume":"31","author":"BC Boer","year":"2016","unstructured":"Boer BC, de Graaff F, Brusse-Keizer M, Bouman DE, Slump CH, Slee-Valentijn M, et al. Skeletal muscle mass and quality as risk factors for postoperative outcome after open colon resection for cancer. Int J Colorectal Dis. 2016;31(6):1117\u201324.","journal-title":"Int J Colorectal Dis"},{"key":"3058_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.994499","volume":"9","author":"L Bardoscia","year":"2022","unstructured":"Bardoscia L, Besutti G, Pellegrini M, Pagano M, Bonelli C, Bonelli E, et al. Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation. Front Nutr. 2022;9: 994499.","journal-title":"Front Nutr"},{"issue":"12","key":"3058_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.2319","volume":"3","author":"EMC Feliciano","year":"2017","unstructured":"Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML, et al. Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol. 2017;3(12): e172319.","journal-title":"JAMA Oncol"},{"issue":"1","key":"3058_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10522-014-9539-7","volume":"16","author":"R Kob","year":"2015","unstructured":"Kob R, Bollheimer LC, Bertsch T, Fellner C, Djukic M, Sieber CC, et al. Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis? Biogerontology. 2015;16(1):15\u201329.","journal-title":"Biogerontology"},{"issue":"2","key":"3058_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/jcsm.12901","volume":"13","author":"CW Li","year":"2022","unstructured":"Li CW, Yu K, Shyh-Chang N, Jiang Z, Liu T, Ma S, et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. 2022;13(2):781\u201394.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3058_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.arr.2016.09.008","volume":"35","author":"A Kalinkovich","year":"2017","unstructured":"Kalinkovich A, Livshits G. Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev. 2017;35:200\u201321.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"3058_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00441-010-0955-y","volume":"340","author":"SJ Peters","year":"2010","unstructured":"Peters SJ, Vanhaecke T, Papeleu P, Rogiers V, Haagsman HP, van Norren K. Co-culture of primary rat hepatocytes with rat liver epithelial cells enhances interleukin-6-induced acute-phase protein response. Cell Tissue Res. 2010;340(3):451\u20137.","journal-title":"Cell Tissue Res"},{"key":"3058_CR29","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2147\/JIR.S441623","volume":"17","author":"RY Mai","year":"2024","unstructured":"Mai RY, Lu TL, Lu RJ, Zeng C, Lian F, Li LQ, et al. C-reactive protein-albumin ratio (CAR): a more promising inflammation-based prognostic marker for patients undergoing curative hepatectomy for hepatocellular carcinoma. J Inflamm Res. 2024;17:919\u201331.","journal-title":"J Inflamm Res"},{"issue":"6","key":"3058_CR30","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s10147-024-02512-4","volume":"29","author":"TK Sahin","year":"2024","unstructured":"Sahin TK, Ozbay Y, Altunbulak AY, Altunbulak HI, Onur MR, Ceylan F, et al. Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy. Int J Clin Oncol. 2024;29(6):822\u201331.","journal-title":"Int J Clin Oncol"},{"issue":"8","key":"3058_CR31","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/ueg2.12627","volume":"12","author":"A Surov","year":"2024","unstructured":"Surov A, Wienke A, Borggrefe J, Hinnerichs M, Seidensticker R, \u00d6cal O, et al. Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: a subanalysis of the SORAMIC trial. United Eur Gastroenterol J. 2024;12(8):1016\u201327.","journal-title":"United Eur Gastroenterol J"},{"issue":"10","key":"3058_CR32","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.biocel.2013.05.032","volume":"45","author":"N Johns","year":"2013","unstructured":"Johns N, Stephens NA, Fearon KC. Muscle wasting in cancer. Int J Biochem Cell Biol. 2013;45(10):2215\u201329.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"3058_CR33","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/SLA.0000000000003049","volume":"271","author":"S Tsai","year":"2020","unstructured":"Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, et al. Importance of normalization of CA19-9 levels following neoadjuvant therapy in patients with localized pancreatic cancer. Ann Surg. 2020;271(4):740\u20137.","journal-title":"Ann Surg"},{"issue":"3","key":"3058_CR34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41416-020-0901-z","volume":"123","author":"JP Lin","year":"2020","unstructured":"Lin JP, Lin JX, Ma YB, Xie JW, Yan S, Wang JB, et al. Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer. Br J Cancer. 2020;123(3):418\u201325.","journal-title":"Br J Cancer"},{"issue":"7","key":"3058_CR35","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/nutrit\/nuac005","volume":"80","author":"Y Li","year":"2022","unstructured":"Li Y, Li C, Wu G, Yang W, Wang X, Duan L, et al. The obesity paradox in patients with colorectal cancer: a systematic review and meta-analysis. Nutr Rev. 2022;80(7):1755\u201368.","journal-title":"Nutr Rev"},{"issue":"7","key":"3058_CR36","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1245\/s10434-014-3594-9","volume":"21","author":"E Oki","year":"2014","unstructured":"Oki E, Emi Y, Kusumoto T, Sakaguchi Y, Yamamoto M, Sadanaga N, et al. Phase II study of docetaxel and S-1 (DS) as neoadjuvant chemotherapy for clinical stage III resectable gastric cancer. Ann Surg Oncol. 2014;21(7):2340\u20136.","journal-title":"Ann Surg Oncol"},{"key":"3058_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejca.2020.02.013","volume":"130","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Yang X, Yan C, Feng R, Sah BK, Yang Z, et al. Effect of apatinib plus neoadjuvant chemotherapy followed by resection on pathologic response in patients with locally advanced gastric adenocarcinoma: a single-arm, open-label, phase II trial. Eur J Cancer. 2020;130:12\u20139.","journal-title":"Eur J Cancer"},{"issue":"1","key":"3058_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.advms.2023.02.005","volume":"68","author":"K Nurczyk","year":"2023","unstructured":"Nurczyk K, Nowak N, Carlson R, Skoczylas T, Wallner G. Pre-therapeutic molecular biomarkers of pathological response to neoadjuvant chemotherapy in gastric and esophago-gastric junction adenocarcinoma: a systematic review and meta-analysis. Adv Med Sci. 2023;68(1):138\u201346.","journal-title":"Adv Med Sci"},{"issue":"4","key":"3058_CR39","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/mus.25966","volume":"57","author":"CE Feather","year":"2018","unstructured":"Feather CE, Lees JG, Makker PGS, Goldstein D, Kwok JB, Moalem-Taylor G, et al. Oxaliplatin induces muscle loss and muscle-specific molecular changes in Mice. Muscle Nerve. 2018;57(4):650\u20138.","journal-title":"Muscle Nerve"},{"issue":"2","key":"3058_CR40","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1001\/jamaoncol.2019.4668","volume":"6","author":"EM Cespedes Feliciano","year":"2020","unstructured":"Cespedes Feliciano EM, Chen WY, Lee V, Lee V, Albers KB, Prado CM, et al. Body composition, adherence to anthracycline and taxane-based chemotherapy, and survival after nonmetastatic breast cancer. JAMA Oncol. 2020;6(2):264\u201370.","journal-title":"JAMA Oncol"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-025-03058-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-025-03058-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-025-03058-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T15:16:36Z","timestamp":1760714196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-025-03058-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["3058"],"URL":"https:\/\/doi.org\/10.1007\/s00595-025-03058-2","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (revised in 2013) and was approved by the institutional review board of Qinghai University Clinical Medical College (approval number: P-SL-2024-009).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all patients for inclusion in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}